2m 2m 2m 2m 2m 2m 2m
- $122,022.00Market Cap
- 900.00%1-Year Change
- Medical DevicesIndustry
Rafina Innovatns (VICA)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 77
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
No data found
Peers
Statistics
MoreInformation as of 06/02/2026
Company Profile
Rafina Innovations Inc. engages in the research, development, commercialization, and marketing of medical technologies. It operates through two segments, Clinics and Technology. The company also operates prosthetics and orthotics, and diabetic foot total rehabilitation clinics in Southern Europe, the Middle East, and North Africa. In addition, it is involved in the research, development, and commercialization of medical devices, methods, and products in the fields of prosthetics, orthotics, rehabilitation, bioengineering, mobility, diabetes, diabetic foot, tissue mechanics, ultrasonics, medical signal processing and analysis, medical technology, orthopedics, and robotic surgery; and licensing of its proprietary technologies. The company was formerly known as HCi Viocare and changed its name to Rafina Innovations Inc. in July 2018. Rafina Innovations Inc. was founded in 2007 and is based in Glasgow, the United Kingdom.
Key Executives
- Paraskevi Pilarinou
- Georgios Thrapsaniotis
- Nikolaos Kardaras
- Evaggelia Moschidou
- Paraskevi Pylarinou
Current Ownership Distribution
- Insiders177.8M (100.00%)
- Institutions0 (0.00%)
- Mutual Funds0 (0.00%)
- Other0 (0.00%)